Is it safe for someone in their seventies to use Ro for weight loss injections, or should I stick to an in-person endocrinologist?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Is it safe for someone in their seventies to use Ro for weight loss injections, or should I stick to an in-person endocrinologist?
3 real searches · 1 real-search pass
FDA Wegovy prescribing information older adults geriatric use dehydration muscle loss semaglutide 2025Google ↗
OBSERVED
FDA Zepbound prescribing information geriatric use older adults tirzepatide 2025Google ↗
OBSERVED
obesity pharmacotherapy older adults 70 muscle loss frailty clinical guidance endocrinologyGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
FDA Wegovy prescribing information older adults geriatric use dehydration muscle loss semaglutide 2025 Google ↗
FDA Zepbound prescribing information geriatric use older adults tirzepatide 2025 Google ↗
obesity pharmacotherapy older adults 70 muscle loss frailty clinical guidance endocrinology Google ↗
- label · accessdata.fda.gov
- These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND® (tirzepatide) Injection, for subcutaneous useInitial U.S. Approval: 2022 · dailymed.nlm.nih.gov
- Expert Consensus on the Management of Obesity in Older Adults (2026 Edition) · pmc.ncbi.nlm.nih.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
FDA Wegovy prescribing information older adults geriatric use dehydration muscle loss semaglutide 2025 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA Zepbound prescribing information geriatric use older adults tirzepatide 2025 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
obesity pharmacotherapy older adults 70 muscle loss frailty clinical guidance endocrinology OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |